E-ISSN 1658-7820
 

Review Article
Online Published: 16 Oct 2024
 


The effect of glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide receptor agonists in nonalcoholic fatty liver disease in type 2 diabetic patients: a systematic review and meta-analysis

Atheer Alshutayli, Essa Alsultan, Muath Alshammari, Faisal Alqahtani, Tuqa Alharbi, Fatimah Alnaim, Seham Alshalahi, Dhai Almuteri, Mohammed Albarqi.


Abstract
Background: Non-alcoholic fatty liver disease (NAFLD) and type 2 diabetes mellitus (T2DM) are prevalent conditions that often coexisting and significantly impact patient health. Glucagon-like peptide-1 (GLP-1) receptor agonists, such as liraglutide, dulaglutide, semaglutide, efinopegdutide, and cotadutide, have shown promise in managing these conditions. This study aims to evaluate the efficacy of these medications on metabolic and liver-related outcomes in patients with T2DM and NAFLD.
Methodology: A comprehensive analysis of multiple randomized controlled trials (RCTs) was conducted to assess the impact of GLP-1 receptor agonists on body mass index (BMI), glycemic control (HbA1c), blood pressure, lipid profiles, and liver enzymes. The patient populations, interventions, and control groups were compared across these studies to derive comprehensive insights.
Results: GLP-1 receptor agonists significantly improved metabolic and liver-related outcomes. Patients on liraglutide, dulaglutide, and semaglutide showed marked reductions in BMI and HbA1c levels, indicating effective weight management and glycemic control. Improvements in lipid profiles were observed, with notable reductions in triglycerides and increases in high-density lipoprotein levels. Significant reductions in liver enzymes (alanine aminotransferase and aspartate aminotransferase) were reported, particularly with efinopegdutide and cotadutide, indicating improved liver health. Gastrointestinal side effects, such as nausea and vomiting, were common but generally mild and transient.
Conclusion: The study demonstrates that GLP-1 receptor agonists are effective in managing both metabolic and liver-related outcomes in patients with T2DM and NAFLD. These medications significantly reduce BMI, improve glycemic control and lipid profiles, and lower liver enzyme levels, indicating enhanced liver health. While mild gastrointestinal side effects were reported, the overall safety and efficacy profiles of these drugs make them promise therapeutic options. Future research should focus on long-term effects and optimal dosing strategies to maximize therapeutic benefits and minimize side effects.

Key words: "Non-alcoholic Fatty Liver Disease" "Diabetes Mellitus, Type 2" "Glucagon-Like Peptide-1 Receptor Agonists" " insulinotropic polypeptide receptor agonists " "Randomized controlled trials"


 
ARTICLE TOOLS
Abstract
PDF Fulltext
How to cite this articleHow to cite this article
Citation Tools
Related Records
 Articles by Atheer Alshutayli
Articles by Essa Alsultan
Articles by Muath Alshammari
Articles by Faisal Alqahtani
Articles by Tuqa Alharbi
Articles by Fatimah Alnaim
Articles by Seham Alshalahi
Articles by Dhai Almuteri
Articles by Mohammed Albarqi
on Google
on Google Scholar


How to Cite this Article
Pubmed Style

Alshutayli A, Alsultan E, Alshammari M, Alqahtani F, Alharbi T, Alnaim F, Alshalahi S, Almuteri D, Albarqi M. The effect of glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide receptor agonists in nonalcoholic fatty liver disease in type 2 diabetic patients: a systematic review and meta-analysis. IJMDC. Online First: 16 Oct, 2024. doi:10.24911/IJMDC.51-1725216272


Web Style

Alshutayli A, Alsultan E, Alshammari M, Alqahtani F, Alharbi T, Alnaim F, Alshalahi S, Almuteri D, Albarqi M. The effect of glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide receptor agonists in nonalcoholic fatty liver disease in type 2 diabetic patients: a systematic review and meta-analysis. https://www.ijmdc.com/?mno=218242 [Access: November 27, 2024]. doi:10.24911/IJMDC.51-1725216272


AMA (American Medical Association) Style

Alshutayli A, Alsultan E, Alshammari M, Alqahtani F, Alharbi T, Alnaim F, Alshalahi S, Almuteri D, Albarqi M. The effect of glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide receptor agonists in nonalcoholic fatty liver disease in type 2 diabetic patients: a systematic review and meta-analysis. IJMDC. Online First: 16 Oct, 2024. doi:10.24911/IJMDC.51-1725216272



Vancouver/ICMJE Style

Alshutayli A, Alsultan E, Alshammari M, Alqahtani F, Alharbi T, Alnaim F, Alshalahi S, Almuteri D, Albarqi M. The effect of glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide receptor agonists in nonalcoholic fatty liver disease in type 2 diabetic patients: a systematic review and meta-analysis. IJMDC, [cited November 27, 2024]; Online First: 16 Oct, 2024. doi:10.24911/IJMDC.51-1725216272



Harvard Style

Alshutayli, A., Alsultan, . E., Alshammari, . M., Alqahtani, . F., Alharbi, . T., Alnaim, . F., Alshalahi, . S., Almuteri, . D. & Albarqi, . M. (2024) The effect of glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide receptor agonists in nonalcoholic fatty liver disease in type 2 diabetic patients: a systematic review and meta-analysis. IJMDC, Online First: 16 Oct, 2024. doi:10.24911/IJMDC.51-1725216272



Turabian Style

Alshutayli, Atheer, Essa Alsultan, Muath Alshammari, Faisal Alqahtani, Tuqa Alharbi, Fatimah Alnaim, Seham Alshalahi, Dhai Almuteri, and Mohammed Albarqi. 2024. The effect of glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide receptor agonists in nonalcoholic fatty liver disease in type 2 diabetic patients: a systematic review and meta-analysis. International Journal of Medicine in Developing Countries, Online First: 16 Oct, 2024. doi:10.24911/IJMDC.51-1725216272



Chicago Style

Alshutayli, Atheer, Essa Alsultan, Muath Alshammari, Faisal Alqahtani, Tuqa Alharbi, Fatimah Alnaim, Seham Alshalahi, Dhai Almuteri, and Mohammed Albarqi. "The effect of glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide receptor agonists in nonalcoholic fatty liver disease in type 2 diabetic patients: a systematic review and meta-analysis." International Journal of Medicine in Developing Countries Online First: 16 Oct, 2024. doi:10.24911/IJMDC.51-1725216272



MLA (The Modern Language Association) Style

Alshutayli, Atheer, Essa Alsultan, Muath Alshammari, Faisal Alqahtani, Tuqa Alharbi, Fatimah Alnaim, Seham Alshalahi, Dhai Almuteri, and Mohammed Albarqi. "The effect of glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide receptor agonists in nonalcoholic fatty liver disease in type 2 diabetic patients: a systematic review and meta-analysis." International Journal of Medicine in Developing Countries Online First: 16 Oct, 2024. Web. 27 Nov 2024 doi:10.24911/IJMDC.51-1725216272



APA (American Psychological Association) Style

Alshutayli, A., Alsultan, . E., Alshammari, . M., Alqahtani, . F., Alharbi, . T., Alnaim, . F., Alshalahi, . S., Almuteri, . D. & Albarqi, . M. (2024) The effect of glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide receptor agonists in nonalcoholic fatty liver disease in type 2 diabetic patients: a systematic review and meta-analysis. International Journal of Medicine in Developing Countries, Online First: 16 Oct, 2024. doi:10.24911/IJMDC.51-1725216272





Most Viewed Articles
Most Accessed Articles

  • Marginal adaptation of fixed prosthodontics
    Shahad Mohammed Halawani, Sahar Amer Al-Harbi
    IJMDC. 2017; 1(2): 78-84
    » Abstract » doi: 10.24911/IJMDC.1.2.7

  • Parasites in central nervous system
    Amal Ahmed Mohamed, Asmaa Mohamed Mansour
    IJMDC. 2017; 1(2): 72-77
    » Abstract » doi: 10.24911/IJMDC.1.2.6

  • Non-diabetic retinopathy: a case report
    Hassan F. Alkwikbi, Nabil Mamon Abdelfattah, Haithem Mamon Abdelfattah
    IJMDC. 2017; 1(1): 33-37
    » Abstract » doi: 10.24911/IJMDC.1.1.6

  • Vitamin D deficiency among high school female students in Riyadh
    Sahar Mohsen Aldhafeeri, Fatemah Ibraheem Alrawaji, Abrar Mubarak Algharbi, Alanoud Abdullah Alhessan, Ayat Sami Qabaja, Ghaleah Abdulaziz Alnassar, Ghaliah Ofayn Alsulami, Mashael Belal Alrubaian, Norah Abdulaziz Alhatim, Salehah Salih Alotaibi, Zahra Ali Alkhamees
    IJMDC. 2017; 1(1): 18-23
    » Abstract » doi: 10.24911/IJMDC.1.1.4

  • Prognosis of chronic complications of diabetes mellitus (DM) after multiple events of diabetic ketoacidosis (DKA)
    Baraa Faiez Rajab, Anwar Essa Alamrim, Ali Essa Alamri
    IJMDC. 2019; 3(5): 474-479
    » Abstract » doi: 10.24911/IJMDC.51-1546551993

  • Most Downloaded
    Top Downloaded Articles

  • Anti-IL-17 markedly inhibited the in vitro granuloma induced by Schistosoma mansoni soluble egg antigen.
    Asmaa Ezz, Irene S. Gmail, Fatma Elzahraa H. Salem, Rabab Salama, Soad Nady
    IJMDC. 2018; 2(January 2018): 38-46
    » Abstract » doi: 10.24911/IJMDC.2.1.7

  • Vitamin D deficiency among high school female students in Riyadh
    Sahar Mohsen Aldhafeeri, Fatemah Ibraheem Alrawaji, Abrar Mubarak Algharbi, Alanoud Abdullah Alhessan, Ayat Sami Qabaja, Ghaleah Abdulaziz Alnassar, Ghaliah Ofayn Alsulami, Mashael Belal Alrubaian, Norah Abdulaziz Alhatim, Salehah Salih Alotaibi, Zahra Ali Alkhamees
    IJMDC. 2017; 1(1): 18-23
    » Abstract » doi: 10.24911/IJMDC.1.1.4

  • Antibiotic Resistance Crisis
    Nuha Saad Mobarki, Buthaina Abdullah Almerabi, Ahmad Hattan Hattan
    IJMDC. 2019; 3(6): 561-564
    » Abstract » doi: 10.24911/IJMDC.51-1549060699

  • The knowledge of mothers about children malnutrition and associated factors
    Anas Abdulrahman Aljohani, Mujahid Abdulrahman Aljohani
    IJMDC. 2020; 4(1): 7-11
    » Abstract » doi: 10.24911/IJMDC.51-1541620358

  • Knowledge and attitude of caregivers of cerebral palsy children in Riyadh city
    Abdulaziz Alruwaished, Baleegh Ali, Lubna Abdullah Alhowaimil , Abaraa adullah Alhowaimil, Najd Abdullah Alhowaimil, Aminah Alessa
    IJMDC. 2020; 4(1): 12-17
    » Abstract » doi: 10.24911/IJMDC.51-1547833051

  • Most Cited Articles
    Most Cited Articles

  • Antibiotic Resistance Crisis
    Nuha Saad Mobarki, Buthaina Abdullah Almerabi, Ahmad Hattan Hattan
    IJMDC. 2019; 3(6): 561-564
    » Abstract » doi: 10.24911/IJMDC.51-1549060699
    Cited : 34 times [Click to see citing articles]

  • Prevalence of depression, anxiety and stress among diabetes mellitus patients in Arar, Northern Saudi Arabia
    AMohammed Elamin Mukrim, Nujud Muteb D. Alshammari, Wurud Muteb D. Alshammari, Maali Subhi T. Alshammari, Yousef Nasif R. Alshammari, Abdulaziz Sael M. Alshammari, Maisa Hamad F. Alanazi, Abdulelah Abdulrhman F. Alzammam, Muharib Mana M. Alshammari, Slwa Khaled Abu Asyah, Aseel Jamal Alzuhayri, Mushref Saeid Alshammari
    IJMDC. 2019; 3(3): 229-233
    » Abstract » doi: 10.24911/IJMDC.51-1542576396
    Cited : 8 times [Click to see citing articles]

  • Knowledge, attitude, and practice of breast self-examination toward breast cancer among female students at King Saud University in Riyadh, Saudi Arabia
    Abdullah Nasser Alomair, Dania Ghazi Felemban, Mohannad Sami Felemban, Jameel Abdullah Awadain, Ammar Saud Altowairqi, Nawaf Fawzan Alfawzan, Fatimah Mohammed Almazayen, Abdulrahman Jalwi Korkoman, Nawaf Saad Alrusayyis
    IJMDC. 2020; 4(2): 429-434
    » Abstract » doi: 10.24911/IJMDC.51-1576668182
    Cited : 8 times [Click to see citing articles]

  • Population awareness about rheumatoid arthritis in Jazan region, Saudi Arabia
    Ahmad Ali Hazzazi, Mohssen Hassen Ageeli, Ahmed Ali Muyidi, Abdulaziz Mohammad Abulgasim, Abdullah Ahmad Yateemi, Nabil Alhakami
    IJMDC. 2020; 4(3): 668-675
    » Abstract » doi: 10.24911/IJMDC.51-1576010943
    Cited : 4 times [Click to see citing articles]

  • Prevalence and factors associated with depression among health care workers in National Guard Hospital in Riyadh, KSA
    Noor Mohammad AlFahhad
    IJMDC. 2018; 2(September 2018): 92-96
    » Abstract » doi: 10.24911/IJMDC.51-1526306040
    Cited : 4 times [Click to see citing articles]